Menu
Keeping Patients Out
of the Emergency Department
We develop innovative AI- based lung Doppler diagnostic devices. Our technology is suitable for bedside diagnosis and monitoring of cardio-pulmonary diseases in emergency and primary care environments.
Our technology can provide accurate and rapid diagnostics to improve patient care. EchoLogic-Medical technology will potentially:
Improves disease management for the entire patient treatment cycle from initial diagnosis to home monitoring.
EchoLogic-Medical leads the way towards the development of a fast, simple and reliable method for diagnosis of heart and lung diseases.
Does not require use by skilled physicians or specialized technicians in contrast to conventional echo-based devices.
Our AI based devices produces results in 3-5 minutes.
The results of extensive clinical studies show an accuracy of nearly 90%.
Established in 2006, EchoLogic-Medical Ltd. develops innovative ultrasound Doppler systems for the diagnosis and monitoring of cardiac and pulmonary diseases. The company will deliver a fast, reliable and non-invasive method of diagnosis. Our technology has undergone successful clinical trials in the United States, Europe and Israel. The company research and development center is based in Haifa, Israel.
For further information about EchoLogic-Medical technology, contact us at:
Office: +972 4-8500101
Email: info@echologic-medical.com
Caution: Echologic Medical is developing an investigational device. Limited by Federal law for investigational use only in the United States
Send us a quick message and will get back to you as soon as possible.
Send us a quick message and will get back to you as soon as possible.